Patient Square Bets Big on NKTR: A Deep Dive for Investors
A prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
Compare ongoing fees across top dividend ETFs for 2024 to find the funds with the lowest drag on your returns and best value.
28,084 articlesA prominent investor placed a sizable stake in Nektar Therapeutics, sparking questions about the stock's potential. T...
A big hedge fund dumped its entire ServisFirst stake, triggering questions about risk and valuation in regional banks...
When markets swing, some investors rush for safety while others seize opportunities. This guide shows how to approach...
Tech stocks retreat as chipmakers drag the Nasdaq lower and rising yields weigh on growth names after a stronger jobs...
As the 2030s approach, social security benefit cuts become a real risk if lawmakers delay reform. Here’s what could h...
Joby Aviation stock has been on a wild ride as headlines swirl around the company and the eVTOL market. This article ...
Tilray Brands has evolved from a pure-play cannabis company into a diversified player. This guide breaks down what to...
Two specialty retailers sit on opposite ends of the consumer tech spectrum. By unpacking their revenue trends, invest...
As remote work grows, understanding tax deductions for home office 2026 can save you money. This guide breaks down el...
A public clash between a legendary director and a veteran actor isn’t just drama. It’s a window into how money, reput...
After closing on a rental property, one diligence item can determine whether your cash flow meets expectations. This ...
Fresh data suggests U.S. home prices may have found a floor. As affordability stabilizes, demand returns and lenders ...